Buchumschlag

Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first‐line therapy in advanced nonuterine leiomyosarcoma: A multicenter real‐world study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Salih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel, Caner Acar, Imge Akın, Hasan Aslanhan, Mert Iscı, Ceren Kabaoglu, Hamit Bal, Abdullah Sakin, Alper Coskun, Mehmet Sıddık Dilek, Mahmut Kara, Ali Solmaz, Evrican Zin, Aytac Terzi, Fatih Kus, Ilgın Koc Kus, Zafer Arık, Ali Aytac, Özge Demirkıran, Bilgin Demir, Havva Yesil, Sedat Biter, Tolga Koseci, Ertugrul Bayram, Ahmet Unsal, Alper Sevınc, Duygu Ozaskın, Meltem Baykara, Ahmet Unlu, Arıf Kus, Cengiz Karacin, Galip Can Uyar, Osman Sutcuoglu, Esmanur Kaplan, Teoman Sakalar, Elif Sahin, Gamze Emin, Atilla Yıldırım, Ceren Mordag, Irem Ugurlu, Ilhan Hacıbekiroglu, Ibrahim Tunbekici, Ulus Ali Sanli, Erdem Goker, Pınar Gursoy
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	International Journal of Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
DOI:	10.1002/ijc.70212